News Pfizer, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:12 2024-05-03 pm EDT			5-day change	1st Jan Change
27.81 ^USD	+0.40%		+10.10%	-3.40%

11:17am	GSK plc : Back on track
12:23am	Wall Street: optimism ahead of NFP, rates ease	CF

GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech For Infringing MRNA Vaccine Patents	10:12am	AQ
NICE recommends new haemolytic anaemia treatment	10:01am	AQ
AM Best Affirms Credit Ratings of Blue Whale Re Ltd	05:20am	AQ
GSK plc : Back on track	05:17am
Wall Street: optimism ahead of NFP, rates ease	06:23pm	CF
PFIZER INC : Buy rating from DZ Bank	May. 02	ZD
Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28	May. 02	MT
Leerink Adjusts Price Target on Pfizer to $29 From $27	May. 02	MT
BMO Capital Adjusts Pfizer's Price Target to $36 From $33, Keeps Outperform Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	May. 02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	May. 02	PU
Moderna quarterly sales beat expectations but plummet from previous year	May. 02	RE
Morgan Stanley Lifts Price Target on Pfizer to $29 From $28, Keeps Equalweight Rating	May. 02	MT
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Press Release	May. 02	PU
Pfizer : April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid	May. 02	PU
Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup	May. 01	DJ
US Equity Markets Close Mixed Wednesday After Fed Holds Rates Steady	May. 01	MT
Sector Update: Health Care Stocks Rise Late Afternoon	May. 01	MT
PFIZER INC : Jefferies gives a Buy rating	May. 01	ZD
Trending : Pfizer 1Q Earnings Top Estimates; Raises FY24 View	May. 01	DJ

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs